• OPEN AN ACCOUNT
Indian Indices
Sensex
78,639.03 544.39
( 0.70%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
63,705.00 -657.02
(-1.02%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0470742
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
19.12
110373.65
EPS(TTM)
Face Value()
Div & Yield %
126.28
2
0.75
 

Sharp Investments standalone net profit rises 85.71% in the March 2026 quarter
May 04,2026
Net profit of Sharp Investments rose 85.71% to Rs 0.26 crore in the quarter ended March 2026 as against Rs 0.14 crore during the previous quarter ended March 2025. Sales rose 44.44% to Rs 0.26 crore in the quarter ended March 2026 as against Rs 0.18 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.01 crore in the year ended March 2026. There were no net profit/loss reported during the previous year ended March 2025. Sales rose 44.44% to Rs 0.26 crore in the year ended March 2026 as against Rs 0.18 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.260.18 44 0.260.18 44
OPM %100.0077.78 -3.850 -
PBDT0.260.14 86 0.010 0
PBT0.260.14 86 0.010 0
NP0.260.14 86 0.010 0